Headline News about Xenon Pharmaceuticals Inc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Xenon Pharmaceuticals
February 28, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/laboratory-563423-1920_9.jpeg?width=1200&height=800&fit=crop)
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
February 16, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
4 Analysts Have This to Say About Xenon Pharmaceuticals
December 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/30/2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Xenon Pharmaceuticals: Q3 Earnings Insights
November 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Xenon Pharmaceuticals
November 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Expert Ratings for Xenon Pharmaceuticals
July 17, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/28/boeing_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/27/xene_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/27/image20.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Xenon Pharmaceuticals
June 15, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Xenon Pharmaceuticals: Q1 Earnings Insights
May 09, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Xenon Pharmaceuticals Stands With Analysts
April 25, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_133.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2023/11/Stock-Xenonpharma-01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/27/xene.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/27/ituran_location_and_control_-_logo.jpg?width=1200&height=800&fit=crop)
Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On Monday
November 27, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/11/10/nbix.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/25/xene.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Xenon Pharmaceuticals Earnings Preview
February 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Xenon Pharmaceuticals
January 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1563.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
![](https://www.investors.com/wp-content/uploads/2018/12/Stock-DrugDesigner-01-adobe.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.